Comorbidities, concomitant medications and potential drug‐drug interactions with interferon‐free direct‐acting antiviral agents in hepatitis C patients in TaiwanChen‐Hua Liu, Jia‐Horng Kao, Gin‐Ho Lo et al.|Alimentary Pharmacology & Therapeutics|2018Cited by 52
A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infectionJia‐Horng Kao, Wan‐Long Chuang, Rong‐Nan Chien et al.|Liver International|2016Cited by 29
Ledipasvir/sofosbuvir fixed‐dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virusWan‐Long Chuang, Jia‐Horng Kao, Rong‐Nan Chien et al.|Journal of Gastroenterology and Hepatology|2016Cited by 27
Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis‐related complications (Taiwanese chronic hepatitis C cohort)Wei‐Fan Hsu, Cheng‐Yuan Peng, Pei‐Chien Tsai et al.|Journal of Gastroenterology and Hepatology|2021Cited by 23